CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
CRISPR THERAPEUTICS, INC.
This 401(k) plan holds $38M in total assets and serves 466 participants as of 2022. It is sponsored by CRISPR THERAPEUTICS, INC. in Massachusetts. The plan reported positive net income of $2M for the year.
What the Filing Says About CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN
CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN is a 401(k) retirement plan sponsored by CRISPR THERAPEUTICS, INC., headquartered in Massachusetts. As of the 2022 Form 5500 filing, the plan reports $38M in total end-of-year assets and covers 466 participants across the Professional & Technical Services industry. The sponsor's EIN on file with the U.S. Department of Labor is 473173478, and the plan has been effective since 2016-11-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $36M at the beginning of 2022 to $38M at year-end — a gain of 5.3%. Net assets (after liabilities) closed the year at $38M, with reported net income of $2M driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $36M |
| Total Assets (End of Year) | $38M |
| Net Assets (End of Year) | $38M |
| Net Income | $2M |
| Plan Type | 401(k) |
| Employer EIN | 473173478 |
| Plan Effective Date | 2016-11-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (CRISPR THERAPEUTICS, INC.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 466 | $38M |
| 2023 | 1 | 449 | $54M |
| 2024 | 1 | 399 | $67M |
Nearby 401(k) Plans in Massachusetts
Peer 401(k) plans — same state, same plan type — ranked by total assets.
- FIDELITY RETIREMENT SAVINGS PLAN $28.6B · 62,289
- CONSOLIDATED 403(B) PROGRAM OF MASS GENERAL BRIGHAM AND MEMBER ORGANIZATIONS $14.9B · 74,212
- LIBERTY MUTUAL 401(K) PLAN $10.6B · 37,052
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY SUPPLEMENTAL 401(K) PLAN $6.8B · 14,094
- BOSTON SCIENTIFIC CORPORATION 401(K) RETIREMENT SAVINGS PLAN $5.8B · 19,881
Related Data
Guides
Frequently Asked Questions
How much money is in the CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN? ▼
What type of plan is CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN? ▼
Who sponsors the CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN? ▼
How did CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN perform in 2022? ▼
Where can I find official filings for CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN? ▼
How does CRISPR THERAPEUTICS 401(K) RETIREMENT PLAN compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2022.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 473173478.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.